A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

Clinical trial NCT07014826 · RECRUITING

Trial details

NCT number: NCT07014826
Sponsor: Chengdu Suncadia Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Primary IgA Nephropathy

Start date: 2025-06-04
Primary completion: 2027-10-01
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.